Clinical Trial Update: A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System [Phase 1, Phase 2]

View source ↗

Summary

Takeda's TAK-981 was studied in Phase 1/2 trials for advanced solid tumors and hematologic malignancies, but the study was terminated with results posted on 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms
• Lymphoma
• Solid Tumors

Drugs mentioned

• TAK-981

Snippet

Sponsor: Takeda | Conditions: Neoplasms, Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-11-19